Gut dysbiosis may accelerate SLE initiation and progression through multiple mechanisms, including intestinal barrier dysfunction, molecular mimicry, antigen crossreactivity, and metabolite-mediated immune dysregulation [8]
This compromises the entire point of the empty-stomach protocol, as food will catch up to the peptide in the stomach or small intestine
The Cochrane Database of Systematic Reviews (3) CD004326
This may affect levels of ciclosporin, tacrolimus, some statins, some calcium-channel blockers, antiarrhythmics, and direct oral anticoagulants such as apixaban or rivaroxaban
Proper storage and handling procedures are important for maintaining product purity, consistency, and reliability throughout laboratory applications